Table 6.

The association of patients’ perspective with inflammatory markers (t-test for two independent samples, one-way ANOVA, n = 67).

	ECLAM		ESR		ANA
	Mean (SD)	Significance	Mean (SD)	Significance	Mean (SD)	Significance
Disablement		ns		ns		ns
(1) without	1.50 (2.06)		39.39 (15.84)		2.15 (0.88)
(2) partial disability retirement	2.27 (2.64)		33.27 (17.47)		1.86 (0.77)
(3) full disability retirement	2.16 (2.39)		35.74 (16.99)		2.16 (0.77)
SLE status		p ˂ 0.001		p ˂ 0.001		p ˂ 0.001
(1) remission without symptoms	0.30 (0.68)	1vs.3, 2vs.3	17.90 (3.07)	1vs.2,1vs.3, 2vs.3	1.30 (0.48)	1vs.2,1vs.3, 2vs.3
(2) stabilized	1.81 (2.05)		37.35 (15.48)		2.07 (0.74)
(3) with symptoms	4.00 (3.02)		51.17 (11.42)		2.83 (0.39)
Visited physician in the past month		ns		p ˂ 0.05		ns
(1) none	1.53 (1.85)		29.60 (13.33)	1vs3	2.07 (0.80)
(2) once in the past month	1.57 (2.15)		34.61 (15.61)		1.93 (0.72)
(3) at least twice in past month	2.70 (2.79)		43.65 (17.75)		2.30 (0.82)
Being hospitalized in the past year		ns		ns		ns
(1) no	1.78 (2.06)		34.38 (16.16)		1.93 (0.80)
(2) at least once in past year	2.19 (2.75)		39.26 (17.29)		2.26 (0.81)
Health complaints at least once a week of significant intensity		ns		ns		ns
(1) none	1.88 (2.36)		34.96 (16.85)		1.88 (0.85)
(2) one health complaint	2.23 (2.35)		33.18 (14.80)		2.00 (0.82)
(3) two and more health complaints	1.71 (2.41)		41.24 (17.94)		2.33 (0.73)
SLE impact on life		ns		ns		ns
(1) very restrictive	2.73 (2.82)		39.20 (20.55)		2.33 (0.82)
(2) restrictive	1.87 (2.28)		37.97 (15.87)		2.00 (0.78)
(3) moderately or not restrictive	1.46 (2.02)		31.23 (13.31)		2.08 (0.76)